NASDAQ:BRKR
$14.00
(3/15 8:10PM)
+1.0%
| Open | $13.77 |
Mkt Cap | $2.3 Billion |
| High | $14.13 |
52Wk High | $14.37 |
| Low | $13.76 |
52Wk Low | $5.45 |
| Volume | 673,098 |
Avg Vol 10D | 895,700 |
Ockham's Rating/Recommendation Summary
Rating specific information requires Premium Access.
Buy Now
or
Learn More about Ockham's Features and Services.
BRKR Revenue
Cash earnings is the most important factor in our analysis, but it goes without saying that if a company cannot produce sales then there is no ability to generate cash flow. By that logic we look very closely at revenue numbers as our second most important factor in valuing a company's stock. We have established reasonable Price to Sales per share ranges based on historical data of the last 10 years. For, BRKR the high and low end of the Price to Sales per share ratios are 3.12x and 1.04x respectively.
Notice that BRKR's current Price to Sales per share ratio is 2.04x, which is somewhat below its historical weighted average by 2%. Given this level of sales per share, we suggest a neutral share price forecast. To the extent there is a further drop in the Price to Sales ratio from current levels, which would occur through some combination of increased sales per share or a decline in share price, we would only become more positive about the Price to Sales ratio outlook.
BRKR Cash Earnings
Cash Earnings is always one of the most important factors to review for a company and, more importantly, an investment in a stock. BRKR is significantly below its historical average multiple of cash earnings as calculated by Ockham. Similar to our analysis of sales per share, Ockham looks at the last 10 years of cash earnings levels for BRKR to identify where the current high and low price levels have been historically in relation to profit per share. Again, we utilize a weighted average methodology which relies more heavily on recent years of data. This weighted average framework provides us with an average high Price to Cash Earnings ratio per share of 44.68 and a 21.22 low over the same period.
Now that BRKR’s current price is $13.86 and its Price to Cash Earnings ratio is 24.75, we are very positive on its outlook from the cash earnings perspective. In fact, BRKR is now trading a full 25% below its average historical Price to Cash Earnings ratio at these profit per share levels. When our clients ask us why BRKR has great long term potential, the Cash Earnings levels to current stock is one of our primary reasons. But naturally, now we need for the overall market to recognize this disparity.
BRKR Dividends
When determining a company's future prospects for success, Ockham Research sees analysis of dividend payments as a key additional factor. Even though it isn't imperative for BRKR to shell out a dividend in order to receive a positive rating, it can be helpful to further our analysis. As of the time of this report, our data provider does not have historical data for BRKR. Therefore, we are not utilizing the dividends portion in our study. So, we do not know whether BRKR currently pays a dividend at present or not, we have an "expected dividend" payment listed in key fundamentals but cannot varify it.
Bruker Corporation (BRKR) Discussed on CNBC's Mad Money
Bruker Corporation is in the news. Find out how this impacts BRKR trading on Ockham Research.
Springs. We love your show and your books. Cash flow queen. I love that. >> caller: you got it. Here are stocks. Ba boeing, BRKR, brooker bioscience. Thu, china unicom, nordica american tanker, por, portland jim, am I diversified? >> tricky. This is a tricky portfolio, china unicom, I own that for my travel trust. It is a mobile internet tsunami play in china because they have an apple distribution. BRUKER is life science, I think that's fine. That's spec, though. Boeing, you know I like that. I didn't think any of the charge they had to take. This is a multi-year story. You want to get ahead of that. It's a good yield. Portland general is a good yield and here's where I was struggling. Nordic america tanker bought its 17th ships two days ago. I'm afraid that dividend -- you
“… cky portfolio, china unicom, I own that for my travel trust. It is a mobile internet tsunami play in china because they have an apple distribution. BRUKER is life science, I think that's fine. That's spec, though. Boeing, you know I like that. I didn't think any of the charge they had to take. This is a multi-year story. You want to get ahead of that. It's a good yield. Portland general is a good yield and here's where I was struggling. Nordic america tanker bought its 17th ships two days ago. I'm afraid that dividend -- you …”